welcome
Investor's Business Daily

Investor's Business Daily

Health

Health

Novartis Edges Higher As Competition Looms For Entresto

Investor's Business Daily
Summary
Nutrition label

83% Informative

Novartis ( NVS ) reported core earnings of $ 1.98 per share on $13.15 billion in fourth-quarter sales.

Entresto, the company's biggest moneymaker, generated $2.18 billion in sales, growing 33% .

The patent protecting the heart failure treatment is set to expire on July 15 .

VR Score

90

Informative language

94

Neutral language

48

Article tone

formal

Language

English

Language complexity

31

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links